Cecilia Furlong
Stock Analyst at Morgan Stanley
(1.41)
# 3,588
Out of 5,154 analysts
177
Total ratings
42.67%
Success rate
-2.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cecilia Furlong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGHT Sight Sciences | Maintains: Equal-Weight | $6 → $8 | $3.71 | +115.63% | 18 | Dec 2, 2025 | |
| IRTC iRhythm Holdings | Maintains: Overweight | $195 → $205 | $123.59 | +65.87% | 18 | Dec 2, 2025 | |
| MDT Medtronic | Maintains: Overweight | $107 → $117 | $90.90 | +28.71% | 11 | Nov 19, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $115 → $95 | $94.11 | +0.95% | 12 | May 6, 2025 | |
| ISRG Intuitive Surgical | Upgrades: Overweight | $522 → $650 | $490.16 | +32.61% | 13 | Dec 2, 2024 | |
| EMBC Embecta | Maintains: Underweight | $13 → $12 | $9.07 | +32.30% | 12 | Jul 15, 2024 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $75 → $95 | $129.61 | -26.70% | 12 | Feb 28, 2024 | |
| ALC Alcon | Maintains: Equal-Weight | $78 → $85 | $81.33 | +4.51% | 9 | May 11, 2023 | |
| AORT Artivion | Maintains: Equal-Weight | $14 → $15 | $37.04 | -59.50% | 4 | May 8, 2023 | |
| PODD Insulet | Maintains: Equal-Weight | $325 → $343 | $237.01 | +44.72% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $11 → $14 | $2.02 | +593.07% | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $44 → $48 | $17.69 | +171.34% | 4 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $102 | $81.64 | +24.94% | 8 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $56 → $58 | $71.35 | -18.71% | 17 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $20 | $17.06 | +17.23% | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $117 → $131 | $68.10 | +92.36% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $133 | $109.56 | +21.39% | 11 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $270 → $220 | $364.56 | -39.65% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $383 → $378 | $113.31 | +233.60% | 2 | Feb 25, 2022 |
Sight Sciences
Dec 2, 2025
Maintains: Equal-Weight
Price Target: $6 → $8
Current: $3.71
Upside: +115.63%
iRhythm Holdings
Dec 2, 2025
Maintains: Overweight
Price Target: $195 → $205
Current: $123.59
Upside: +65.87%
Medtronic
Nov 19, 2025
Maintains: Overweight
Price Target: $107 → $117
Current: $90.90
Upside: +28.71%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $115 → $95
Current: $94.11
Upside: +0.95%
Intuitive Surgical
Dec 2, 2024
Upgrades: Overweight
Price Target: $522 → $650
Current: $490.16
Upside: +32.61%
Embecta
Jul 15, 2024
Maintains: Underweight
Price Target: $13 → $12
Current: $9.07
Upside: +32.30%
TransMedics Group
Feb 28, 2024
Maintains: Equal-Weight
Price Target: $75 → $95
Current: $129.61
Upside: -26.70%
Alcon
May 11, 2023
Maintains: Equal-Weight
Price Target: $78 → $85
Current: $81.33
Upside: +4.51%
Artivion
May 8, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $37.04
Upside: -59.50%
Insulet
May 5, 2023
Maintains: Equal-Weight
Price Target: $325 → $343
Current: $237.01
Upside: +44.72%
May 3, 2023
Maintains: Equal-Weight
Price Target: $11 → $14
Current: $2.02
Upside: +593.07%
Apr 28, 2023
Maintains: Equal-Weight
Price Target: $44 → $48
Current: $17.69
Upside: +171.34%
Apr 27, 2023
Maintains: Overweight
Price Target: $95 → $102
Current: $81.64
Upside: +24.94%
Apr 27, 2023
Maintains: Overweight
Price Target: $56 → $58
Current: $71.35
Upside: -18.71%
Feb 23, 2023
Maintains: Equal-Weight
Price Target: $18 → $20
Current: $17.06
Upside: +17.23%
Jan 6, 2023
Maintains: Equal-Weight
Price Target: $117 → $131
Current: $68.10
Upside: +92.36%
Jan 6, 2023
Maintains: Overweight
Price Target: $117 → $133
Current: $109.56
Upside: +21.39%
Jul 15, 2022
Maintains: Equal-Weight
Price Target: $270 → $220
Current: $364.56
Upside: -39.65%
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $383 → $378
Current: $113.31
Upside: +233.60%